Bath & Body Works (NYSE:BBWI) Stock Price Up 4.3% – Here’s What Happened

Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) shares shot up 4.3% during trading on Wednesday. The company traded as high as $18.71 and last traded at $18.7650. Approximately 4,267,768 shares changed hands during trading, a decline of 28% from the average daily volume of 5,922,687 shares. The stock had previously closed at $18.00.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. BMO Capital Markets assumed coverage on Bath & Body Works in a report on Tuesday, September 8th. They set a “market perform” rating and a $20.00 price target on the stock. Jefferies Financial Group increased their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Argus reissued a “hold” rating on shares of Bath & Body Works in a report on Wednesday, September 16th. Barclays reduced their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Thursday, August 27th. Finally, Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price objective for the company in a report on Tuesday, August 18th. Four equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.13.

Get Our Latest Report on BBWI

Bath & Body Works Stock Up 7.8%

The stock has a market cap of $4.12 billion, a P/E ratio of 5.32, a PEG ratio of 0.95 and a beta of 1.40. The firm’s fifty day moving average price is $18.14 and its 200-day moving average price is $19.05.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts predict that Bath & Body Works, Inc. will post 2.73 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.9%. The ex-dividend date of this dividend was Friday, August 21st. Bath & Body Works’s payout ratio is presently 20.83%.

Hedge Funds Weigh In On Bath & Body Works

Several institutional investors have recently made changes to their positions in BBWI. Bank of America Corp DE bought a new stake in shares of Bath & Body Works during the 2nd quarter valued at $62,249,000. Hsbc Holdings PLC grew its position in shares of Bath & Body Works by 98.0% during the second quarter. Hsbc Holdings PLC now owns 588,941 shares of the company’s stock valued at $13,651,000 after purchasing an additional 291,470 shares in the last quarter. BlackRock Inc. bought a new position in Bath & Body Works during the second quarter valued at $449,065,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Bath & Body Works in the second quarter worth $2,691,000. Finally, Deutsche Bank AG purchased a new position in shares of Bath & Body Works during the second quarter valued at approximately $3,892,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its portfolio includes body lotions and creams, shower products, fragrances, hand soaps and sanitizers, three-wick candles, wall-plug air fresheners, and other home-fragrance items. The company markets products under the Bath & Body Works brand and regularly introduces seasonal and limited-edition collections.

The company sells its products through a network of company-operated stores, its e-commerce website, and other direct channels.

Recommended Stories

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.